Funded Tech Companies
Anocca
Anocca, operating out of Södertälje, received equity investments from Nidoco AB, AMF and private investors.
Company Overview
Company Name
Anocca
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
Forskargatan 20C
Södertälje, 151 36
SE
Södertälje, 151 36
SE
Phone
Website
Email Address
Company Background Information
Overview
Anocca is a privately held Swedish biotechnology company founded in 2014 with the mission to establish a unique technology platform for analysis of T-cell biology to unlock the therapeutic potential of T-cell immunity. Anocca's technologies enable the highly precise and efficient analysis of T-cell biology required to deliver a range of therapeutics that specifically harness or manipulate T-cell immunity in a number of disease areas. With a focus on delivering TCR-modified T-cell therapies (TCR-T) in oncology, Anocca is rapidly progressing a pipeline of novel T-cell therapies towards clinical trials utilizing our own manufacturing capabilities.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
5/31/2023
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Reagan Jarvis
Chief Financial Officer
Jacob Michlewicz
Chief Information Officer
Ryan Hill
Chief Operating Officer
Viktor Arnkil
Chief Scientific Officer
Hugh Salter
Chief Technical Officer
Luke Pase
Company Investors
- Nidoco AB
- AMF
- Ramsbury
- Mellby Gard
- Michano
- Swedbank Robur
- European Investment Bank
Browse more funded tech companies:
Anobit Technologies | Anode Labs
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs